Analysis of the Arterial Pressure Wave Form Through the Proxima Device

计划入组 10 人 · 首次发布于 2012 年 8 月 24 日

Access to Maternity and Risk Factors in a Non-consultant Population (PROXIMA)

计划入组 500 人 · 首次发布于 2020 年 8 月 10 日

Researches About Proximal Humerus Fractures

计划入组 800 人 · 首次发布于 2020 年 8 月 21 日

B7-H3(Radiopharm Ventures)

histone acetyltransferase activators (Columbia University/Columbia Technology Ventures)

UCH-L1 (Columbia Technology Ventures)

AMARA VENTURES

India

Stoh Ventures, Inc.

United States

Endo Ventures Limited

United States

Rapafusyn Pharmaceuticals Raises $28 Million Series A to Advance Non-Degrading Molecular Glue Platform

BridGene Biosciences Secures $28 Million Series B+ Funding to Advance TEAD Inhibitor BGC-515 Toward Phase 2

Rapafusyn Pharmaceuticals Secures $44 Million Series A to Advance Non-Degrading Molecular Glue Platform